ClinConnect ClinConnect Logo
Search / Trial NCT05404750

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Launched by UNIVERSITY OF PITTSBURGH · May 31, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Harm Reduction Patient Provider Relationship

ClinConnect Summary

This clinical trial, titled "Harm Reduction in HIV Primary Care for PLWH Who Use Drugs," is studying how healthcare providers' attitudes and practices can improve the care of people living with HIV (PLWH) who also use drugs. The goal is to understand how supportive relationships between patients and providers, as well as specific care strategies known as harm reduction, can help reduce the stigma these patients face in healthcare settings. By exploring these relationships, the researchers hope to find ways to enhance HIV care and improve health outcomes for patients who may be at higher risk due to their drug use.

To participate in this study, you need to be at least 18 years old, living with HIV, and have been receiving HIV care at one of the study sites for at least a year. You should also have used illicit substances or prescription drugs for non-medical reasons recently or in your lifetime. The researchers are looking for both patients and healthcare providers from specific clinics who meet these criteria. Participants can expect to contribute to important research that could lead to better healthcare practices and ultimately help reduce health inequalities for individuals living with HIV who use drugs.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Providers' Inclusion Criteria
  • Working at one of our 3 study sites (UPMC HIV/AIDS Program, Positive Health Clinic, or 1917 Clinic) or one of their partner sites offering substance use treatment (Internal Medicine Recovery Engagement Program, Center for Inclusion Health, or UAB's Outpatient-Based Opioid Treatment Clinic) for at least one year
  • Providing service or care to PLWH or people who use drugs at high risk for HIV acquisition
  • Working in one of the following positions: front desk/patient engagement, social worker, nurse, medical assistant, advanced practice provider, or physician
  • Able to verbally consent, read, and speak English
  • 2. Patient Inclusion Criteria
  • Living with HIV
  • Age 18 or older
  • Able to verbally consent, read, and speak English
  • Receiving HIV medical care from one of the study sites for at least one year
  • Lifetime or recent use (past 3 months) of illicit substances (excluding marijuana) or prescription drugs for non-medical reasons in accordance with the NIDA-Modified ASSIST 2.0.
  • Exclusion Criteria:
  • -

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Birmingham, Alabama, United States

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Mary Hawk, DrPH

Principal Investigator

University of Pittsburgh

Emma Kay, PhD

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials